Centene Corporation

CNC · Healthcare

$65.23

Markedsværdi: 32.22B USDUdbytteafkast:
AdvancedEr det et godt tidspunkt at købe Centene Corporation? Spørg Copenvest AIFå et Advanced AI-bud på timing, risiko og hvad tracked investorer gør.Spørg Copenvest AI

Indlæser diagram…

Nyheder

Seneste overskrifter for denne aktie

Zacks Investment Research4. sep. 2026, 13.14

4 Stocks Trading Near 52-Week High With Room to Rise Further

Four stocks trading near their 52-week highs—PRA Group, Centene, BILL Holdings, and Par Pacific—demonstrate strong earnings growth and positive momentum. Using a screening strategy that targets stocks with robust fundamentals, undervalued metrics, and consistent price momentum, these companies are positioned for continued upside despite trading at elevated price levels.

Zacks Investment Research2. sep. 2026, 16.21

Here's Why Investors Should Stay Neutral on TDOC Stock for Now

Teladoc Health (TDOC) is positioned for growth through chronic care expansion, international presence, and its upcoming Teladoc One platform, with the stock trading at a valuation discount. However, the company faces headwinds from declining BetterHelp revenues, intense virtual care competition, and persistent unprofitability with a $16.5 billion accumulated deficit.

Zacks Investment Research31. aug. 2026, 08.03

Best Growth Stocks to Buy for August 31st

Zacks highlights three stocks with Rank #1 buy ratings and strong growth potential: Centene Corporation (managed care), Valero Energy Corporation (energy), and monday.com Ltd. (software). All three have seen significant increases in consensus earnings estimates over the last 60 days and possess favorable PEG ratios compared to their respective industries.

Zacks Investment Research27. aug. 2026, 13.03

5 Defensive Stocks to Buy as Consumer Confidence Hits 7-Month Low

With consumer confidence hitting its lowest level since January due to inflation concerns and labor market uncertainty, five defensive stocks from consumer staples, healthcare, and utilities sectors are recommended: COCO, DAR, CNC, EXC, and AMRX. These stocks offer upside potential with strong earnings growth estimates and improved analyst consensus over the past 60 days.